8-K
FORM 8-K
- Company
- PharmaCyte Biotech, Inc.
- Filed
- February 15, 2012
- Period of Report
- February 9, 2012
- Accession Number
- 0001262463-12-000033
An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →